TalkyLand

TalkyLand
Google PlayApp Store
talkyland logo

TalkyLand is a self-training language-development app that encourages speech in children who are beginning to use language and in children with communication disorders. Through child interaction, its voice-AI engine analyzes spoken responses while its progress-analysis engine provides personalized content and reports based on each child’s developmental level and age. Story-based activities with engaging characters make play-based language learning available anytime, anywhere.

Digital Therapeutics (DTx)
–Based Learning

Digital Therapeutics (DTx) –Based Learning

Self-Training Language
Development

Self-Training Language Development

Level-Based Personalized
Content

Level-Based Personalized Content

Feature

TalkyLand is widely used across special education schools, general schools, kindergartens, and public institutions. It has established itself as a trusted educational tool validated in real educational settings and continues to earn strong confidence from teachers and institutions.

MFDS Clinical Trial Plan Approved

TalkyLand has received approval from the Ministry of Food and Drug Safety (MFDS) for its Digital Therapeutics (DTx) clinical trial plan. With clinical evidence in place, it is preparing for the medical-device regulatory pathway.

Field-Validated EdTech Solution

TalkyLand is actively used in special schools, general schools, kindergartens, and public institutions, where it is recognized as a trusted educational resource. Currently, pilot programs are being conducted in 12 schools (4 special education schools and 8 general schools). Based on these results, TalkyLand is evolving into customized, school-specific programs.

Personalized Content Delivery

TalkyLand scientifically evaluates each learner’s language development status through its proprietary level assessment. Based on the results, it provides personalized learning content and vocabulary tailored to the learner’s developmental and chronological age. Vocabulary sets are structured around daily- life age benchmarks, making the content effective not only for special education students but for all children.

Learning Management System (LMS)

TalkyLand generates personalized learning reports on a daily and weekly basis, allowing educators and caregivers to visually track and analyze learning progress. The platform also supports individualized configuration options, enabling customized content delivery aligned with each student’s proficiency level.

Clinical Evidence
A language intervention solution based on precise data proven through clinical trials at Kyungpook National University Hospital. TalkyLand_DTx has confirmed its therapeutic efficacy by significantly improving articulation accuracy in children with Autism Spectrum Disorder (ASD).
Proven Efficacy

Proven Efficacy

Significant Improvement in Articulation Accuracy (U-TAP2)

Expansion of Expressive Ability

Expansion of Expressive Ability

Improvement in Noun/Verb usage and Expressive Language Equivalent Age

Thorough Safety

Thorough Safety

Zero Adverse Events Confirmed Safe Digital Therapeutic Device

Verification of Articulation Accuracy Efficacy and Statistical Significance

In the clinical trial, the TalkyLand group achieved an improvement in articulation accuracy approximately 6.5 times greater than the control group, with statistical significance (p = 0.015). The result demonstrates a meaningful, data-supported improvement in children’s speech-sound accuracy.

* An 8-week evaluation of improvement in language-disorder symptoms among elementary school students aged 7–12 diagnosed with autism spectrum disorder (ASD).

Verification of Articulation Accuracy Efficacy and Statistical Significance
Verification of Accelerated Development in Expressive Language Age (ELA)

Verification of Accelerated Development in Expressive Language Age (ELA)

After eight weeks of training, children’s expressive-language ability increased by the equivalent of about eight months. While the control group advanced by 1.6 months, children using TalkyLand advanced by 8.1 months—approximately five times faster growth over the same period.